|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
|
(Address of principal executive offices)
|
(State)
|
(Zip Code)
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
|
|
The
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
|
Smaller reporting company
|
Emerging growth company
|
1
|
|
1
|
|
5 |
|
14
|
|
16
|
|
23
|
|
24
|
|
24
|
Item 10. |
Directors, Executive Officers and Corporate Governance
|
Name
|
Age
|
Position
|
||
Paul B. Prager
|
64
|
Co-Founder, Chairman of the Board of Directors and Chief Executive Officer
|
||
Nazar M. Khan
|
47
|
Co-Founder, Chief Operating Officer, Chief Technology Officer and Executive Director
|
||
Kerri M. Langlais
|
46
|
Chief Strategy Officer and Executive Director
|
||
Michael C. Bucella
|
36
|
Director
|
||
Walter E. Carter
|
63
|
Director
|
||
Catherine J. Motz
|
52
|
Director
|
||
Jason G. New
|
54
|
Director
|
||
Steven T. Pincus
|
64
|
Director
|
||
Lisa A. Prager
|
66
|
Director
|
Name
|
Age
|
Position
|
||
Paul B. Prager
|
64
|
Chief Executive Officer and Chair of the Board of Directors
|
||
Kenneth Deane
|
53
|
Chief Accounting Officer and Treasurer
|
||
Patrick Fleury
|
45
|
Chief Financial Officer
|
||
Nazar Khan
|
47
|
Chief Operating Officer, Chief Technology Officer and Director
|
||
Kerri Langlais
|
46
|
Chief Strategy Officer and Director
|
• |
Paul B. Prager - Chief Executive Officer and Chair of the Board of Directors
|
• |
Patrick A. Fleury - Chief Financial Officer (from May 16, 2022)
|
• |
Kenneth J. Deane - Chief Financial Officer (until May 16, 2022), Chief Accounting Officer and Treasurer (from May 16, 2022)
|
Name and Principal Position (1)
|
Year
|
Salary
($)(2)
|
Bonus ($)(3)
|
Stock
Awards
($)(4)
|
All Other
Compensat
ion ($)(5)
|
Total ($)
|
|||||||||||||||
Paul B. Prager, Chief Executive Officer
|
2022
|
740,588
|
-
|
-
|
17,355
|
757,943
|
|||||||||||||||
and Chair of the Board of Directors
|
2021
|
612,248
|
-
|
-
|
12,980
|
625,228
|
|||||||||||||||
Patrick A. Fleury, Chief Financial Officer
|
2022
|
215,803
|
-
|
3,300,000
|
251
|
3,516,054
|
|||||||||||||||
Kenneth J. Deane, Chief Accounting Officer and Treasurer
|
2022
|
325,634
|
-
|
990,000
|
17,244
|
1,332,878
|
(1) |
On May 16, 2022, the Company appointed Mr. Fleury as its Chief Financial Officer, replacing Mr. Deane, who served as the Company’s Chief Financial Officer at such time. As of May
16, 2022, Mr. Deane continued to serve the Company as its Chief Accounting Officer and Treasurer.
|
(2) |
In October 2022, Mr. Prager voluntarily elected to defer payment of a portion of his 2022 base salary equal to $219,230, and such amount remained unpaid as of December 31, 2022.
|
(3) |
The annual cash bonus payouts for fiscal year 2022 have not been determined or approved as of the date of this Amendment. To the extent any such bonuses are
earned by Messrs. Prager, Fleury and/or Deane, we will file a Current Report on Form 8-K with such information when those amounts are determined by our Compensation Committee. No annual cash bonuses were paid for fiscal year 2021.
|
(4) |
Represents the aggregate grant date fair value of the restricted stock units (“RSUs”) granted in 2022 computed in accordance with Financial Accounting
Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, Compensation-Stock Compensation. On May 16, 2022, Mr. Fleury was granted 1,000,000 RSUs as an “employment inducement grant” within the meaning of Rule
5635(c)(4) of the Nasdaq Listing Rules. The amount disclosed does not correspond to the actual value that may be realized by Mr. Fleury for this award. On May 16, 2022, Mr. Deane was granted an award of 300,000 RSUs under our TeraWulf
2021 Omnibus Incentive Plan (the “2021 Plan”). See Notes 2 and 16 to our consolidated financial statements included in our 2022 Form 10-K for
the assumptions made in determining these values.
|
(5) |
Amounts reported in the Summary Compensation Table for 2022 as “All Other Compensation” for fiscal 2022 include the following: for Mr. Prager: employer matching contributions to defined
contribution plans of $15,250 and life insurance premiums of $2,105; for Mr. Fleury: life insurance premiums of $251; and for Mr. Deane: employer matching contributions to defined contribution plans of $15,250 and life insurance premiums
of $1,994. On four occasions in 2022, family members or guests of Mr. Prager accompanied him on business trips on a Company leased aircraft. In those instances, there is no incremental cost to the Company, and as a result, no amount is
reflected in the table.
|
Stock Awards
|
||||||||
Name
|
Number of
Shares or
Units of
Stock That
Have Not
Vested (#)
|
Market
Value of
Shares of
Units of
Stock That
Have Not
Vested ($)
|
||||||
Paul B. Prager(1)
|
-
|
-
|
||||||
Patrick A. Fleury
|
1,000,000
|
(2)
|
665,600
|
(3)
|
||||
Kenneth J. Deane
|
300,000
|
(4)
|
199,680
|
(3)
|
(1) |
As of December 31, 2022, Mr. Prager did not hold any outstanding equity awards.
|
(2) |
This award of RSUs vests 25% on each of the first two anniversaries of May 16, 2022 and 50% on the third anniversary of May 16, 2022.
|
(3) |
The market values of the RSUs shown above are based on the $0.6656 closing market price of our common stock on the
last trading day of fiscal year 2022, December 30, 2022.
|
(4) |
One-third of this award of RSUs vests on each of the first three anniversaries of May 16, 2022.
|
(i) |
a lump-sum cash payment payable on the 60th calendar day following the termination date in an aggregate amount equal to the annual base salary that would have been paid to the named executive
officer during the 12-month (for Mr. Prager only, 18-month) period (the “severance period”) following the termination date;
|
(ii) |
continued coverage during the severance period (or until such named executive officer becomes eligible for comparable coverage under the medical health plans of a successor employer, if earlier)
for such named executive officer and any eligible dependents under all of the Company’s health and welfare plans in which such named executive officer and any such dependents participated immediately prior to the termination date, subject
to any active-employee cost-sharing or similar provisions in effect for such named executive officer thereunder as of immediately prior to the termination date; provided,
however, that such coverage will not be provided in the event the Company would be subject to any excise tax under Section 4980D of the Code or other penalty or
liability pursuant to the provisions of the Patient Protection and Affordable Care Act of 2010, as amended, and, in lieu of providing the coverage described above, the Company will instead pay such named executive officer a fully taxable
monthly cash payment in an amount such that, after payment by such named executive officer of all taxes on such payment, such named executive officer retains an amount equal to the applicable premiums for such month, with such monthly
payment being made on the last day of each month for the remainder of the severance period;
|
(iii) |
a prorated portion of the annual bonus payable with respect to the fiscal year in which such termination occurs determined on a daily basis, based on target level of achievement of the applicable
performance goals for such year, payable on the 60th calendar day following the termination date;
|
(iv) |
any previously earned annual bonus payable to such named executive officer for any fiscal year completed on or before the termination date that has not been paid to such named executive officer
as of the termination date, payable on the 60th calendar day following the termination date; and
|
(v) |
all outstanding equity awards then-held by such named executive officer (excluding the Inducement Award) will be treated in accordance with the terms of the applicable equity plan and award
agreements; provided, however, that, with respect to awards that vest (x) solely based on
continued service with the Company, such named executive officer will vest in any tranche scheduled to vest in accordance with the applicable award agreement during the severance period and (y) based on the achievement of performance
criteria, based on the actual achievement of such performance criteria that occurs during the severance period.
|
(i) |
a prorated portion of the annual bonus payable with respect to the fiscal year in which such termination occurs determined on a daily basis, based on target level of achievement of the applicable
performance goals for such year, payable on the 60th calendar day following the termination date; and
|
(ii) |
any previously earned annual bonus payable to such named executive officer for any fiscal year completed on or before the termination date that has not been paid to such named executive officer
as of the termination date, payable on the 60th calendar day following the termination date.
|
Year
|
Summary
Compensati
on Table
Total for
PEO 1 (Paul
B. Prager)
|
CAP to PEO
1 (Paul B.
Prager)
|
Summary
Compensati
on Table
Total for
PEO 2
(Glenn
Sandgren)1
|
CAP to PEO
2 (Glenn
Sandgren)
|
Average
Summary
Compensati
on Table
Total for
Non-PEO
NEOs
|
Average
CAP to
Non-PEO
NEOs
|
Value of
Initial Fixed
$100
Investment
Based On
Total
Shareholder
Return
|
Net Loss
|
||||||||||||||||||||||||
|
(1
|
)
|
(2
|
)
|
(1
|
)
|
(2
|
)
|
(3
|
)
|
(4
|
)
|
(5
|
)
|
(6
|
)
|
||||||||||||||||
2022
|
$
|
757,943
|
$
|
757,943
|
-
|
-
|
$
|
2,424,466
|
$
|
712,106
|
$
|
6.68
|
$
|
(90,791,000
|
)
|
|||||||||||||||||
2021
|
$
|
625,228
|
$
|
625,228
|
$
|
964,343
|
$
|
820,233
|
$
|
405,734
|
$
|
405,734
|
$
|
150.96
|
$
|
(95,683,000
|
)
|
(1) |
The dollar amounts reported in this column are the amounts of total compensation reported for our Principal Executive Officer (“PEO”) for
each corresponding year in the “Total” column of the Summary Compensation Table, which for 2022, includes our current PEO Paul B. Prager (PEO 1), and for 2021, includes our current PEO Paul B. Prager (PEO 1) and former PEO Glenn Sandgren
(PEO 2).
|
(2) |
The dollar amounts reported in this column represent the amount of “compensation actually paid” to our PEO for the
applicable fiscal year, as computed in accordance with Item 402(v) of Regulation S-K, which for 2022, includes our current PEO Paul B. Prager, and for
2021, includes our current PEO Paul B. Prager and former PEO Glenn Sandgren. The dollar amounts do not reflect the actual amount of compensation earned by or paid to such executives during the applicable year. In accordance with the
requirements of Item 402(v) of Regulation S-K, the adjustments in the table below were made to the total compensation for each year to determine the compensation actually paid. No
adjustments were made to Mr. Prager’s compensation reported in the “Total” column of the Summary Compensation Table as no equity compensation was granted to or outstanding for Mr. Prager during 2022 and 2021. No adjustments were made
to Mr. Sandgren’s compensation reported in the “Total” column of the Summary Compensation Table for the fair value of at year-end of his outstanding and unvested equity awards granted in 2021 as such awards were cancelled and
settled/exercised in connection with the Company’s completion of its business combination, including the related mergers, with IKONICS on December 13, 2021 and, as a result, such values were already included in Mr. Sandgren’s
compensation reported in the “All Other Compensation” and “Total” columns of the Summary Compensation Table for 2021.
|
Glenn
Sandgren
|
||||
Fiscal Year
|
2021
|
|||
Total from Summary Compensation Table
|
$
|
964,343
|
||
(-) Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year
|
$
|
144,110
|
||
(+) Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year
|
$
|
N/A
|
||
(+) Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years
|
$
|
N/A
|
||
(+) Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which
Applicable Vesting Conditions Were Satisfied During Fiscal Year
|
$
|
N/A
|
||
Compensation Actually Paid
|
$
|
820,233
|
(3) |
The dollar amounts reported in this column represent the average of the amounts reported for the Company’s non-PEO named executive officers (“Non-PEO NEOs”) as a group in the
“Total” column of the Summary Compensation Table in each applicable year. For purposes of calculating the average amounts in each applicable year, the names of each of the Non-PEO NEOs include are as follows: (a) for 2022: Patrick A.
Fleury and Kenneth J. Deane; and (b) for 2021: Nazar M. Khan, Kerri M. Langlais, Claude P. Piguet and Kenneth D. Hegman.
|
(4) |
The dollar amounts reported in this column represent the average amount of “compensation actually paid” to the Non-PEO NEOs as a group in the applicable year as computed in accordance with Item
402(v) of Regulation S-K. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the Non-PEO NEOs as a group during the applicable year. In accordance with the requirements of Item 402(v) of
Regulation S-K, the adjustments in the table below were made to the average total compensation for the Non-PEO NEOs as a group for each year to determine the compensation actually paid, using the same methodology described in Note 2
above.
|
|
Non-PEO NEOs
|
|||||||
Fiscal Year
|
2021
|
2022
|
||||||
Average Total from Summary Compensation Table
|
$
|
405,734
|
$
|
2,424,466
|
||||
(-) Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year
|
$
|
N/A
|
$
|
2,145,000
|
||||
(+) Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year
|
$
|
N/A
|
$
|
432,640
|
||||
(+) Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years
|
$
|
N/A
|
$
|
N/A
|
||||
(+) Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which
Applicable Vesting Conditions Were Satisfied During Fiscal Year
|
$
|
N/A
|
$
|
N/A
|
||||
Average Compensation Actually Paid
|
$
|
405,734
|
$
|
712,106
|
(5) |
Cumulative TSR is calculated by dividing the difference between the Company’s share price at the end and the
beginning of the measurement period by the Company’s share price at the beginning of the measurement period. The Company did not declare dividends for the year ended December 31, 2022 and the period from February 8, 2021 (date
of inception) to December 31, 2021.
|
(6) |
Dollar amounts reported in this column represent the amount of net loss reflected in the Company’s audited financial statements for the year ended December 31, 2022 and the
period from February 8, 2021 (date of inception) to December 31, 2021.
|
Cash retainer
|
$
|
60,000
|
||
Lead independent director (additional cash retainer)
|
$
|
25,000
|
||
Committee chairmanship (additional cash retainers)
|
Audit Committee Chair: $25,000
Compensation Committee Chair: $25,000
|
Restricted stock units that vest on the first anniversary of the date of grant
|
Each non-employee director will receive an annual grant of restricted stock units with a grant date value of $90,000
The lead independent director will receive an additional annual grant of restricted stock units with a grant date value of $25,000
|
Name(1)
|
Fees Earned
or
Paid in Cash
($)(2)
|
Stock
Awards
($)(3)
|
Total
($)
|
|||||||||
Walter E. Carter
|
$
|
68,176
|
$
|
137,099
|
$
|
205,275
|
||||||
Catherine J. Motz
|
$
|
48,124
|
$
|
137,099
|
$
|
185,223
|
||||||
Jason G. New
|
$
|
48,124
|
$
|
137,099
|
$
|
185,223
|
||||||
Steven T. Pincus
|
$
|
68,176
|
$
|
175,180
|
$
|
243,356
|
||||||
Lisa A. Prager
|
$
|
68,176
|
$
|
137,099
|
$
|
205,275
|
||||||
Michael C. Bucella
|
$
|
34,603
|
$
|
117,126
|
$
|
151,729
|
(1) |
Mr. Bucella was appointed to the Board on March 4, 2022.
|
(2) |
Amounts set forth in this column represent the aggregate dollar amount of all fees earned or paid in cash for services as a director, including basic retainer fees and committee and/or chair fees
under our non-employee director compensation program. On March 4, 2023, our board modified our non-employee director compensation policy to permit participating directors to elect to receive cash retainers accrued since the beginning of
the fourth fiscal quarter of 2022 in shares of our common stock in lieu of cash, with the number of shares of common stock granted to be equal to the applicable cash retainer divided by the fair market value of our common stock on the
last trading day of the applicable fiscal quarter, provided, however, that, with respect to cash retainers accrued during the fourth fiscal quarter of 2022, the number of shares of our common stock granted will be equal to the applicable
cash retainer divided by the greater of (a) the closing price of our common stock on December 30, 2022 and (b) the closing price of our common stock on the date the election is made. All of our directors elected to receive their
respective cash retainers accrued in the fourth quarter of 2022 in shares of our common stock.
|
(3) |
Amounts set forth in this column represent the aggregate grant date fair value of the RSU awards granted to certain of our directors in 2022 computed in accordance with FASB ASC Topic 718.
|
Plan Category
|
Number of
securities to be
issued upon
exercise of
outstanding
options, warrants
and rights
(a)
|
Weighted-average
exercise price of
outstanding
options, warrants
and rights
(b)
|
Number of
securities
remaining
available for
future issuance
under equity
compensation
plans (excluding
securities reflected
in column (a))
(c)
|
|||||||||
Equity compensation plans approved by security holders
|
-
|
-
|
-
|
|||||||||
Equity compensation plans not approved by security holders(1)
|
2,013,832
|
-
|
12,646,285
|
(2)
|
||||||||
Total
|
2,013,832
|
-
|
12,646,285
|
(1) |
Includes our 2021 Plan, which was assumed in connection with the IKONICS merger, and shares of our common stock available for issuance upon the settlement of RSUs granted to
Mr. Fleury in connection with his appointment to Chief Financial Officer on May 16, 2022 in accordance with Nasdaq Listing Rule 5635(c)(4).
|
(2) |
There are 12,646,285 shares of common stock that remain available for grant under our 2021 Plan, which may be granted to those recipients permitted by the rules
of the Nasdaq. In addition, the 2021 Plan provides for an automatic increase in the number of shares reserved for issuance thereunder. The share pool will automatically increase each fiscal year following May 13, 2021, which began fiscal
year 2022 and will end with fiscal year 2026, by the lesser of (i) 1% of the total number of shares of our common stock outstanding on the last day of the immediately preceding fiscal year on a fully diluted basis assuming that all shares
available for issuance under the 2021 Plan are issued and outstanding or (ii) such number of shares of our common stock determined by our board of directors. The increase shall occur on the first day of each such fiscal year or another
day selected by our board of directors during such fiscal year.
|
Item 12. |
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
• |
each person, or group of affiliated persons, who we know to beneficially own more than 5% of our capital stock;
|
• |
each of our named executive officers for fiscal year 2022 who are currently serving;
|
• |
each of our current directors; and
|
• |
all of our current directors and executive officers as a group.
|
Shares of Common Stock
Beneficially Owned+
|
||||||||
Number
|
Percent
|
|||||||
5% Stockholders
|
||||||||
Stammtisch Investments LLC(1)
|
25,524,121
|
12.04
|
%
|
|||||
Bryan Pascual(2)
|
19,920,650
|
9.31
|
%
|
|||||
Revolve Capital LLC(3)
|
19,718,387
|
9.22
|
%
|
|||||
Named Executive Officers and Directors
|
||||||||
Paul Prager(1)(4)
|
56,347,760
|
26.72
|
%
|
|||||
Nazar Khan(5)
|
17,539,308
|
8.22
|
%
|
|||||
Kerri Langlais(6)
|
1,322,151
|
*
|
||||||
Michael Bucella(7)
|
63,532
|
*
|
||||||
Walter Carter
|
76,449
|
*
|
||||||
Catherine Motz
|
38,532
|
*
|
||||||
Jason New(8)
|
1,517,789
|
*
|
||||||
Steven Pincus(9)
|
61,309
|
*
|
||||||
Lisa Prager
|
52,865
|
*
|
||||||
All current directors and executive
officers as a group (9 persons)
|
78,019,695
|
36.12
|
%
|
* |
Less than 1%.
|
(1) |
Consists of 25,524,121 shares of our Common Stock owned directly by Stammtisch Investments LLC (“Stammtisch”), a Delaware limited liability company over which
Stammtisch may be deemed to have sole voting and dispositive power. Paul Prager is the sole manager of Stammtisch and has voting and dispositive power over the shares of our Common Stock owned by Stammtisch. See footnote 4 below.
|
(2) |
Based on a Schedule 13D/A filed with the SEC on March 2, 2023. Consists of (i) 18,083,348 shares of our Common Stock owned directly by Bayshore, (ii) 250,000 shares of our Common Stock into which
the Series A Convertible Preferred Stock, par value $0.001 per share (the “Series A Preferred Stock”) held directly by the BJP Revocable Trust are convertible, and (iii) 1,587,302 shares of our Common Stock underlying warrants exercisable
at the holder’s option. Bryan Pascual is the sole trustee of the BJP Revocable Trust, which is the controlling member of Bayshore. Accordingly, Bryan Pascual may be deemed to have beneficial ownership over the shares held directly by
Bayshore and the BJP Revocable Trust. The address of Bryan Pascual, Bayshore and the BJP Revocable Trust is 53 Palmeras Street, Suite 601, San Juan, Puerto Rico 00901.
|
(3) |
Based on a Schedule 13D/A filed with the SEC on February 14, 2023 and Form 4 filed on March 2, 2023. Consists of (i) 17,860,622 shares of our Common Stock owned directly by Revolve; (ii) 270,463
shares of our Common Stock into which the shares of Series A Preferred Stock held directly by Revolve are convertible; and (iii) 1,587,302 shares of our Common Stock underlying warrants exercisable at the holder’s option. Lauren O’Rourke
is the sole member and manager of Revolve and may be deemed to have voting and dispositive power over the shares of our Common Stock owned by Revolve. The address of Revolve is 339 Dorado Beach East, Dorado, Puerto Rico 00646.
|
(4) |
Consists of (i) 25,524,121 shares of our Common Stock beneficially owned by Stammtisch, (ii) 654,706 shares of our Common Stock directly held by Lucky Liefern
LLC (“Lucky Liefern”), (iii) 475,000 shares of our Common Stock directly held by Heorot, (iv) 8,510,638 shares of our Common Stock directly held by Somerset Operating Company, LLC (“Somerset”); (v) 7,315,736 shares of our Common Stock
directly held by Allin WULF LLC (“Allin WULF”), which includes 2,579,365 shares underlying warrants, exercisable at any time at the option of the holder thereof; and (vi) 14,867,559 shares of the Common Stock directly held by various
individuals, trusts and limited liability companies which have executed irrevocable proxies in favor of Paul Prager. Paul Prager is the sole manager and president of Stammtisch, the managing member of Lucky Liefern, the managing member of
Heorot, the sole managing member of Somerset and the sole managing member of Allin WULF, and in such capacities may be deemed to beneficially own the shares of Common Stock beneficially owned by Stammtisch and held directly by each of
Lucky Liefern, Heorot, Somerset and Allin WULF.
|
(5) |
Consists of 17,539,308 shares of our Common Stock, which includes 1,388,889 shares of our Common Stock underlying warrants, exercisable at any time at the option of the holder, owned individually
and by various trusts and limited liability companies over which Nazar Khan may be deemed to have dispositive control.
|
(6) |
Consists of (i) 864,701 shares of our Common Stock owned by a trust over which Kerri Langlais may be deemed to have dispositive control and (ii) 25,100 shares of our Common Stock into which the
shares of Series A Preferred Stock held directly by Kerri Langlais are convertible.
|
(7) |
Consists of (i) 25,000 shares of our Common Stock into which the shares of Series A Preferred Stock held directly by Michael Bucella are convertible; and (ii) 38,532 shares of our Common Stock.
|
(8) |
Consists of (i) 38,532 shares of our Common Stock owned directly by Mr. New; (ii) 1,429,257 shares of our Common Stock owned by Mining Assets, LLC (“Mining Assets”) and (iii) 50,000 shares of our
Common Stock into which shares of Series A Preferred Stock are convertible held by Y CLUB 101, LLC. Jason New is the sole manager of Mining Assets and a managing member of Y Club 101, LLC, and in such capacities may be deemed to
beneficially own the shares of Common Stock held directly by each of Mining Assets and Y Club 101, LLC.
|
(9) |
Consists of (i) 5,000 shares of our Common Stock into which the shares of Series A Preferred Stock held directly by Steven Pincus are convertible; and (ii) 56,309 shares of Common Stock.
|
|
Number of
securities to be
issued upon
exercise of
outstanding
options, warrants
and rights
(a)
|
Weighted-average
exercise price of
outstanding
options, warrants
and rights
(b)
|
Number of
securities
remaining
available for
future issuance
under equity
compensation
plans (excluding
securities reflected
in column (a))
(c)
|
|||||||||
Plan Category
|
||||||||||||
Equity compensation plans approved by security holders
|
-
|
-
|
-
|
|||||||||
Equity compensation plans not approved by security holders(1)
|
2,013,832
|
-
|
12,646,285
|
(2)
|
||||||||
Total
|
2,013,832
|
-
|
12,646,285
|
(1) |
Includes our 2021 Plan, which was assumed in connection with the IKONICS merger, and shares of our common stock available for issuance upon the settlement of RSUs granted to
Mr. Fleury in connection with his appointment to Chief Financial Officer on May 16, 2022 in accordance with Nasdaq Listing Rule 5635(c)(4).
|
(2) |
There are 12,646,285 shares of common stock that remain available for grant under our 2021 Plan, which may be granted to those recipients permitted by the rules of the Nasdaq.
In addition, the 2021 Plan provides for an automatic increase in the number of shares reserved for issuance thereunder. The share pool will automatically increase each fiscal year following May 13, 2021, which began fiscal year 2022 and
will end with fiscal year 2026, by the lesser of (i) 1% of the total number of shares of our common stock outstanding on the last day of the immediately preceding fiscal year on a fully diluted basis assuming that all shares available
for issuance under the 2021 Plan are issued and outstanding or (ii) such number of shares of our common stock determined by our board of directors. The increase shall occur on the first day of each such fiscal year or another day
selected by our board of directors during such fiscal year.
|
Item 13. |
Certain Relationships and Related Transactions, and Director Independence
|
• |
the amounts involved exceeded or will exceed $120,000; and
|
• |
any of our directors, executive officers or holders of more than 5% of our capital stock, or any member of the immediate family of the foregoing persons, had or will have a direct or indirect
material interest.
|
|
Years Ended
|
|||||||
Fee Category
|
December 31,
2022
|
December 31,
2021
|
||||||
Audit Fees
|
$
|
472,500
|
$
|
366,999
|
||||
Audit-Related Fees
|
297,575
|
167,037
|
||||||
Tax Fees
|
102,165
|
-
|
||||||
All Other Fees
|
-
|
|||||||
Total
|
$
|
872,240
|
$
|
534,036
|
Item 15. |
Exhibits, Financial Statement Schedules
|
Exhibit Number | Description | |
(2.1)
|
||
(2.2)
|
||
(2.3)
|
||
(2.4)
|
||
(2.5)
|
||
(3.1)
|
||
(3.2)
|
||
(3.3)
|
||
(3.4)
|
Exhibit Number | Description | |
(3.5)
|
||
4.1
|
||
(4.2)
|
||
(4.3)
|
||
(4.4)
|
||
(4.5)
|
||
(4.6)
|
||
(10.1)
|
||
(10.2)
|
Exhibit Number | Description | |
(10.3)
|
||
(10.4)
|
||
(10.5)
|
||
(10.6)
|
||
(10.7)
|
||
(10.8)
|
||
(10.9)*
|
||
(10.10)*
|
||
(10.11)
|
||
(10.12)
|
Exhibit Number | Description | |
(10.13)
|
||
(10.14)
|
||
10.15
|
||
(10.16)
|
||
(10.17)
|
||
(10.18)
|
||
(10.19)
|
||
(10.20)
|
||
(10.21)
|
||
(10.22)
|
||
(10.23)
|
Exhibit Number | Description | |
(10.24)
|
||
(10.25)
|
||
(10.26)
|
||
(10.27)
|
||
(10.28)
|
||
(10.29)
|
||
(10.30)
|
||
(10.31)
|
||
(10.32)
|
||
(10.33)
|
Exhibit Number | Description | |
(10.34)†
|
||
(10.35)
|
||
(10.36)†
|
||
(10.37)
|
||
(10.38)
|
||
(10.39)
|
||
(10.40)†
|
||
(10.41)†
|
||
21.1
|
||
23.1
|
||
**31.1
|
||
**31.2
|
||
***32.1
|
Exhibit Number | Description | |
***32.2
|
||
101.INS*
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded
within the Inline XBRL document)
|
|
101.SCH*
|
Inline XBRL Taxonomy Extension Schema Document.
|
|
101.LAB*
|
Inline XBRL Taxonomy Extension Label Linkbase Document.
|
|
101.PRE*
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
104*
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
|
*
|
Executive compensation plans and arrangements.
|
†
|
Certain portions of this exhibit have been redacted pursuant to Item 601(b)(2)(ii) and Item 601(b)(10)(iv) of Regulation S-K, as
applicable. The Company agrees to furnish supplementally an unredacted copy of the exhibit to the Commission upon its request.
|
**
|
Filed herewith.
|
***
|
Furnished herewith.
|
TERAWULF INC.
|
||||
(Registrant)
|
||||
May 5, 2023
|
By:
|
/s/ Patrick A. Fleury
|
||
(Date)
|
Paatrick A. Fleury |
|||
|
(Chief Financial Officer)
(Principal Financial Officer)
|